bioMérieux SA Logo

bioMérieux SA (BMXMF)

OTC

Currency in USD
83.17
0.00 (0.00%)

Closed

Aug 24, 2026

Day's Range

80.66
83.17

52 wk Range

77.00
148.00

Overview - BMXMF - bioMérieux SA

Key Statistics

Valuation

Enterprise Value

11.15B

P/E (Trailing)

‪18.27‬

Price / Sales (TTM)

‪2.45‬

Price / Book

‪1.95‬

EV / EBITDA

‪9.09‬

Profitability

Profit Margin

‪11.59%‬

Operating Margin

‪15.23%‬

Return on Assets

‪7.23%‬

Return on Equity

‪11.22%‬

Ownership

Shares Outstanding

117.98M

Float

40.02M

Held by Insiders

‪66.46%‬

Held by Institutions

‪16.76%‬

Price stats

Beta

‪0.57‬

50-Day Avg

‪79.88‬

200-Day Avg

‪103.06‬

Dividends

Payout Ratio

‪25.12%‬

Frequency

Annual

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - BMXMF - bioMérieux SA

Peer Comparison

Compared with companies in Diagnostics & Research listed on OTC.

Profile Summary - BMXMF - bioMérieux SA

About

bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through…

SectorHealthcare
IndustryDiagnostics & Research
Employees14.14K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.